Matti Annala

9PUBLICATIONS
77CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Jun 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|Apr 05, 2024
Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancer.

Heini Ml Kallio, Kalle Savolainen, Tuomo Virtanen

|Mar 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi

Pageof 2